Weight-loss injections that have become famous for helping people shed pounds may also help some patients with advanced cancer live longer when the disease has spread to the brain, according to a new study.
These medicines belong to a group of drugs called GLP-1 receptor agonists, and they include Wegovy and Ozempic. They were first developed to treat type 2 diabetes, but over the past few years they have drawn global attention because many people taking them experience significant weight loss.
